43.67
+0.55(+1.28%)
Currency In USD
Address
One Kendall Square
Cambridge, MA 02139-1562
United States of America
Phone
781-315-4600
Website
Sector
Healthcare
Industry
Biotechnology
Employees
101
First IPO Date
October 03, 2019
| Name | Title | Pay | Year Born |
| Mr. Ram Aiyar MBA, Ph.D. | Chief Executive Officer, President & Director | 844,866 | 1978 |
| Dr. Jean-Francois Formela M.D., MBA | Co-Founder & Independent Director | 8,206 | 1957 |
| Mr. Nessan Bermingham Ph.D. | Co-Founder & Independent Chairman of the Board | 202,137 | 1973 |
| Mr. Vineet Agarwal M.B.A. | Chief Financial Officer | 811,770 | 1982 |
| Dr. Joshua Rosenthal Ph.D. | Co-Founder & Advisor | 0 | N/A |
| Mr. Jeffrey M. Cerio J.D., Pharm.D. | Senior Vice President & General Counsel | 0 | N/A |
| Mr. Todd Chappell M.B.A. | Chief Operating Officer | 0 | 1973 |
| Ms. Stephanie Engels | Senior Vice President and Head of People & Culture | 0 | N/A |
| Mr. Andrew Fraley Ph.D. | Co-Founder & Advisor | 0 | N/A |
| Mr. Marco A. Passini Ph.D. | Vice President & Head of CNS biology | 0 | N/A |
Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is based in Cambridge, Massachusetts.